Orthofix Medical Inc. Common Stock (DE) (OFIX) Stock Price

OFIXStock

$9.38−38.49%52W

Market Cap$382.07M

P/E—

PEG Ratio48.83

Div yield—

Beta0.66

OFIX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-36.16%

Price vs S&P 500 (4W)6.13%

PEG Ratio48.83

VGM Score50.78

P/CF (Annual)11.46x

Book Value / Share (Quarterly)$10.54

P/TBV (Annual)1.59x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)21.30%

Cash Flow / Share (Quarterly)$-0.68

Price vs S&P 500 (YTD)-50.05%

Gross Margin (TTM)71.31%

Net Profit Margin (TTM)-7.41%

EPS (TTM)$-1.53

10-Day Avg Trading Volume0.40M

EPS Excl Extra (TTM)$-1.53

Revenue Growth (5Y)15.13%

EPS (Annual)$-2.33

ROI (Annual)-14.74%

Gross Margin (Annual)68.83%

Net Profit Margin (5Y Avg)-11.96%

Cash / Share (Quarterly)$2.55

Revenue Growth QoQ (YoY)3.85%

ROA (Last FY)-10.84%

Revenue Growth TTM (YoY)2.99%

EBITD / Share (TTM)$-0.67

ROE (5Y Avg)-17.61%

Operating Margin (TTM)-4.70%

Cash Flow / Share (Annual)$-0.03

P/B Ratio0.89x

P/B Ratio (Quarterly)0.86x

Net Income / Employee (Annual)$-57,400

EV / Revenue (TTM)0.62x

Net Interest Coverage (TTM)-4.19x

ROA (TTM)-7.17%

EV / EBITDA (TTM)269.94x

EPS Incl Extra (Annual)$-2.33

Current Ratio (Annual)2.45x

Quick Ratio (Quarterly)1.53x

3-Month Avg Trading Volume0.38M

52-Week Price Return-38.49%

Revenue / Employee (TTM)$519,100

Tangible BV / Share (Quarterly)$8.92

P/S Ratio (Annual)0.46x

Asset Turnover (Annual)0.97x

52-Week High$16.99

Operating Margin (5Y Avg)-8.76%

EPS Excl Extra (Annual)$-2.33

CapEx CAGR (5Y)7.34%

Tangible BV CAGR (5Y)4.94%

26-Week Price Return-26.26%

Quick Ratio (Annual)1.30x

13-Week Price Return-19.00%

Total Debt / Equity (Annual)0.39x

Current Ratio (Quarterly)2.84x

Enterprise Value$512.88M

Revenue / Share Growth (5Y)-0.19%

Asset Turnover (TTM)0.97x

Book Value / Share Growth (5Y)-9.29%

Revenue / Employee (Annual)$512,300

Inventory Turnover (Annual)1.42x

Pretax Margin (Annual)-11.04%

Cash / Share (Annual)$2.06

3-Month Return Std Dev46.60%

Gross Margin (5Y Avg)70.14%

Net Income / Employee (TTM)$-38,500

EBITDA Interim CAGR (5Y)-8.18%

ROE (Last FY)-20.49%

Net Interest Coverage (Annual)-1.90x

EPS Basic Excl Extra (Annual)$-2.33

P/FCF (TTM)16.02x

Receivables Turnover (TTM)6.28x

Total Debt / Equity (Quarterly)0.55x

EPS Incl Extra (TTM)$-1.53

Receivables Turnover (Annual)6.08x

ROI (TTM)-9.58%

P/S Ratio (TTM)0.46x

Pretax Margin (5Y Avg)-10.64%

Revenue / Share (Annual)$20.76

Tangible BV / Share (Annual)$9.47

Price vs S&P 500 (52W)-54.02%

Year-to-Date Return-38.13%

5-Day Price Return1.08%

EPS Normalized (Annual)$-2.33

ROA (5Y Avg)-10.73%

Net Profit Margin (Annual)-11.21%

Month-to-Date Return-0.32%

Cash Flow / Share (TTM)$-2.76

EBITD / Share (Annual)$-1.34

Operating Margin (Annual)-9.90%

LT Debt / Equity (Annual)0.35x

P/CF (TTM)23.49x

ROI (5Y Avg)-14.15%

LT Debt / Equity (Quarterly)0.52x

EPS Basic Excl Extra (TTM)$-1.53

P/TBV (Quarterly)1.02x

P/B Ratio (Annual)1.33x

Inventory Turnover (TTM)1.34x

Pretax Margin (TTM)-7.24%

Book Value / Share (Annual)$11.30

Price vs S&P 500 (13W)-21.68%

Beta0.66x

P/FCF (Annual)7.64x

Revenue / Share (TTM)$20.37

ROE (TTM)-14.05%

52-Week Low$8.50

vGradeB

gGradeC

mGradeC

vgmGradeC

OFIX Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 5, 2026	-$0.03	$0.07	+334.00%(+$0.10)
Q1 2026	May 5, 2026	-$0.29	-$0.11	+61.03%(+$0.18)
Q4 2025	Feb 24, 2026	$0.41	$0.24	-42.70%(-$0.18)
Q3 2025	Nov 4, 2025	$0.12	$0.20	+64.67%(+$0.08)
Q2 2025	Aug 5, 2025	$0.04	$0.13	+223.50%(+$0.09)

OFIX Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.09

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
OFIXOrthofix Medical Inc. Common Stock (DE)	B	C	C	0.5x	15.1%	71.3%	-4.7%	$9.38
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About Orthofix Medical Inc. Common Stock (DE)

Orthofix Medical Inc. is a medical device company specializing in orthopedic and spine solutions. The Global Spine segment, which generates the majority of revenue, provides bone growth therapies, spinal implants, biologics, and enabling technologies for spinal procedures. The Global Limb Reconstruction segment offers solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies.

OFIX Next Earnings Report

Report dateNov 3, 2026

QuarterQ3 2026

Report timeBMO

EPS estimate$0.11

Revenue estimate$210.52M

Also reporting on Nov 3, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

OFIX Insider Transactions

SellOct 1, 2026
FISHER PATRICK G
Officer
Shares: 150Value: $1,416
BuySep 21, 2026
JUNIPER INVESTMENT COMPANY, LLC
Beneficial Owner of more than 10% of a Class of Security
Shares: 310,000Value: $2.73M
SellSep 1, 2026
FISHER PATRICK G
Officer
Shares: 150Value: $1,408
SellAug 18, 2026
FISHER PATRICK G
Officer
Shares: 1,295Value: $13,067

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for October 2026

Companies in Related Industries

PACBPacific Biosciences of California, Inc.Lab Analytical Instruments
MASS908 Devices Inc. Common StockLab Analytical Instruments
SENSSenseonics Holdings, Inc. Common StockIndustrial Instruments
FOSLFossil Group, Inc.Watches & Clocks
PREPrenetics Global Limited Class A Ordinary ShareLab Analytical Instruments
CVCapsoVision, Inc. Common StockElectromedical Equipment
SMTISanara MedTech Inc. Common StockOrthopedic & Prosthetic Devices
OPTXSyntec Optics Holdings, Inc. Class A Common StockOptical Instruments & Lenses

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.1

Buy

Consensus rating

52-Week Range

Low$8.50

High$16.99